For example, GLP-2r agonists have been used in the treatment of inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis) (25) because they can promote intestinal mucosal repair and regeneration, improving patients’ symptoms and quality of life. The gene discussed is GLP2R; the disease is ulcerative colitis.